New Alzheimer's drug approved in U.S. despite concerns about effectiveness

U.S. government health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease.